Int. J. Mol. Sci., 2022 · DOI: 10.3390/ijms231911255 · Published: September 24, 2022
Neuropathic pain, a persistent condition resulting from somatosensory system damage, affects a significant portion of the population and responds poorly to common analgesics. This study investigates the role of the Aryl hydrocarbon receptor (AhR) in regulating neuropathic pain using nerve explant culture and a chronic constrictive nerve injury (CCI) model in mice. The study found that AhR deletion worsened nerve damage and inflammation, while the AhR agonist omeprazole attenuated these effects. This suggests that AhR agonists could be potential candidates for treating neuropathic pain. Researchers used nerve explants from wild-type and AhR-knockout mice to examine omeprazole's ability to prevent nerve degeneration. They also subjected both types of mice to chronic constrictive nerve injury, treating some with omeprazole, and then analyzed neurobehavior and tissues.
AhR agonists like omeprazole may offer a new approach for treating neuropathic pain.
Further research into AhR's mechanisms in nerve injury could lead to more targeted therapies.
The study supports clinical trials to evaluate the efficacy of AhR agonists in patients with neuropathic pain.